We are live on
!
Find out more
FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
1-Year Est. Return
47.04%
This Fund
S&P 500
This Quarter
Est. Return
+35.74%
1 Year Est. Return
-47.04%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$124M
Cap. Flow
% of AUM
83.06%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
9
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
|
+$60.8M |
| 2 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
+$16.8M |
| 3 |
Quantum-Si Incorporated
QSI
|
+$12M |
| 4 |
Disc Medicine
IRON
|
+$7.96M |
| 5 |
Cullinan Oncology
CGEM
|
+$7.6M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $85.6M | 57.37% |
+5,227,307
| New | +$60.8M |
|
|
HLTH
2
DELISTED
Cue Health Inc. Common Stock
HLTH
| $20.5M | 13.73% |
+1,527,103
| New | +$16.8M |
|
|
3
Quantum-Si Incorporated
QSI
$189M
| $12.6M | 8.43% |
+1,598,125
| New | +$12M |
|
|
4
Disc Medicine
IRON
$2.9B
| $7.09M | 4.75% |
+81,171
| New | +$7.96M |
|
|
THRX
5
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.95M | 3.99% |
+468,820
| New | +$7.08M |
|
|
6
Cullinan Oncology
CGEM
$1.1B
| $5.88M | 3.94% |
+381,002
| New | +$7.6M |
|
|
KNTE
7
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.17M | 3.46% |
+291,667
| New | +$6.15M |
|
8
Compass Therapeutics
CMPX
$407M
| $3.49M | 2.34% |
+1,100,000
| New | +$3.65M |
|
9
Adicet Bio
ACET
$79.9M
| $2.97M | 1.99% |
+10,625
| New | +$1.82M |
|
Similar funds
SHI
SAM
LUGPSI
KXA
PGM
ACM
KCM
ALFIA